$BSX

AI Analysis

Generated on May 11, 2026

AI Score
76/ 100
Buy$BSX

Boston Scientific Corporation

$BSXNYSEHealthcareLarge-Cap

Boston Scientific develops medical devices for interventional cardiology, cardiac rhythm management, neuromodulation, and endoscopy.

Market Cap
$120.0B
Revenue (TTM)
$16.5B
+18.0%
Net Income (TTM)
$2.2B
+25.0%
EPS (TTM)
$1.50
P/E Ratio
55.0
Dividend Yield
0.0%
52-Week Range
$55-$95
Beta
0.82
Dimension Scores
Fundamental
72
Technical
72
Sentiment
78
Risk / Reward
72
Momentum
78
FundTechSentRiskMome
Financial Health
Profitability
77strong
Growth
81strong
Liquidity
80strong
Solvency
74strong
Efficiency
70strong

Valuation, technical analysis, investment thesis, risk assessment and more for $BSX

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.